These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9586869)

  • 21. Can the DRL 72s schedule selectively reveal antidepressant drug activity?
    Jackson A; Koek W; Colpaert FC
    Psychopharmacology (Berl); 1995 Jan; 117(2):154-61. PubMed ID: 7753961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of DRL in differentiating anxiolytic and neuroleptic properties of CNS drugs.
    Canon JG; Lippa AS
    Pharmacol Biochem Behav; 1977 May; 6(5):591-3. PubMed ID: 19772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential-reinforcement-of-low-rate-schedule performance and nicotine administration: a systematic investigation of dose, dose-regimen, and schedule requirement.
    Kirshenbaum AP; Brown SJ; Hughes DM; Doughty AH
    Behav Pharmacol; 2008 Oct; 19(7):683-97. PubMed ID: 18797245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitization to amphetamine on the differential-reinforcement-of-low-rate 72-s schedule.
    Balcells-Olivero M; Richards JB; Seiden LS
    Psychopharmacology (Berl); 1997 Oct; 133(3):207-13. PubMed ID: 9361325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naloxone blocks the effects of chlordiazepoxide on acquisition but not performance of differential reinforcement of low rates of response (DRL).
    Tripp G; McNaughton N; Oei TP
    Psychopharmacology (Berl); 1987; 91(1):112-8. PubMed ID: 2881314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of central cholinergic pathways on performance on free-operant avoidance and DRL schedules.
    Kelsey JE; Grossman SP
    Pharmacol Biochem Behav; 1975; 3(6):1043-50. PubMed ID: 1223893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of imipramine in rats as a function of DRL schedule value.
    McGuire PS; Seiden LS
    Pharmacol Biochem Behav; 1980 Nov; 13(5):691-4. PubMed ID: 7443738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinergic blockade, septal lesions, and DRL performance in the rat.
    Ellen P; Aitken WC; Sims T; Stahl JM
    J Comp Physiol Psychol; 1975 Jul; 89(5):409-20. PubMed ID: 1194448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent interaction of alprazolam and caffeine under chronic dose regimens on differential reinforcement of low-rate (DRL 45-s) performance.
    Lau CE; Wang Y; Falk JL
    Psychopharmacology (Berl); 1997 Dec; 134(3):277-86. PubMed ID: 9438677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response disinhibition evoked by the administration of nicotine and nicotine-associated contextual cues.
    Kirshenbaum AP; Johnson MW; Schwarz SL; Jackson ER
    Drug Alcohol Depend; 2009 Nov; 105(1-2):97-108. PubMed ID: 19640659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schedule-dependent effects of haloperidol and amphetamine: multiple-schedule task shows within-subject effects.
    Caul WF; Brindle NA
    Pharmacol Biochem Behav; 2001 Jan; 68(1):53-63. PubMed ID: 11274708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral effects of family-selective inhibitors of cyclic nucleotide phosphodiesterases.
    O'Donnell JM; Frith S
    Pharmacol Biochem Behav; 1999 May; 63(1):185-92. PubMed ID: 10340540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of anticholinergic drugs on DRL performance of rhesus monkeys.
    McDonough JH
    Pharmacol Biochem Behav; 1982 Jul; 17(1):85-90. PubMed ID: 7122671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of caffeine and PD 116,600 on the differential-reinforcement-of-low rate 72-S (DRL 72-S) schedule of reinforcement.
    Marek GJ; Heffner TG; Richards JB; Shaughnessy RA; Li AA; Seiden LS
    Pharmacol Biochem Behav; 1993 Aug; 45(4):987-90. PubMed ID: 8415842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate.
    O'Donnell JM; Seiden LS
    Psychopharmacology (Berl); 1982; 78(3):214-8. PubMed ID: 6818577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat.
    Louis C; Cohen C; Depoortère R; Griebel G
    Neuropsychopharmacology; 2006 Oct; 31(10):2180-7. PubMed ID: 16452986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of selective central muscarinic blockade on schedule-controlled behavior and on the rate-decreasing effects of physostigmine.
    Hymowitz N; Brezenoff HE
    Pharmacol Biochem Behav; 1984 Jul; 21(1):109-15. PubMed ID: 6463084
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Baseline behavior, but not sensitivity to stimulant drugs, differs among spontaneously hypertensive, Wistar-Kyoto, and Sprague-Dawley rat strains.
    Ferguson SA; Paule MG; Cada A; Fogle CM; Gray EP; Berry KJ
    Neurotoxicol Teratol; 2007; 29(5):547-61. PubMed ID: 17689921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in DRH and DRL performance in rats developmentally exposed to an environmental PCB mixture.
    Sable HJ; Powers BE; Wang VC; Widholm JJ; Schantz SL
    Neurotoxicol Teratol; 2006; 28(5):548-56. PubMed ID: 16930942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different effects of 5-HT receptor agonists on operant response in rats under DRL 10-s and DRL 30-s schedules.
    Liao RM; Chang YH
    Proc Natl Sci Counc Repub China B; 2001 Oct; 25(4):223-32. PubMed ID: 11699570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.